Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk

Affiliations

Comment

Mamas Andreas Mamas. Eur Heart J. 2021.

. 2021 Dec 21;42(48):4982-4983.

doi: 10.1093/eurheartj/ehab403.

¹ Keele Cardiovascular Research Group, Keele University, David Weatherall Building, Keele ST5 5BG, UK.

No abstract available

Comment on

Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
Kwok CS, Wong CW, Kontopantelis E, Barac A, Brown SA, Velagapudi P, Hilliard AA, Bharadwaj AS, Chadi Alraies M, Mohamed M, Bhatt DL, Mamas MA. Kwok CS, et al. Eur Heart J. 2021 Mar 7;42(10):1019-1034. doi: 10.1093/eurheartj/ehaa1032. Eur Heart J. 2021. PMID: 33681960
Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
Lozano I, Vegas JM, Rondan J. Lozano I, et al. Eur Heart J. 2021 Dec 21;42(48):4981. doi: 10.1093/eurheartj/ehab401. Eur Heart J. 2021. PMID: 34254121 No abstract available.